Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (151-160 of 336) with videos related to

Pageof 34
Sort By:
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Journal of Medicinal Chemistry|April 17, 2019
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)Jiantao Hu, Biao Hu, Mingliang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selectionShelly S Lo, Patricia B Mumby, John Norton, et al.
Annals of Surgical Oncology|May 22, 2007
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentationErika A Newman, Michael S Sabel, Alexis V Nees, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 7, 2013
Pretreatment worry and neurocognitive responses in women with breast cancerMarc G Berman, Mary K Askren, Misook Jung, et al.
Journal of Virology|July 18, 2008
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancerRafael Contreras-Galindo, Mark H Kaplan, Philippe Leissner, et al.
Journal of Clinical and Experimental Neuropsychology|July 31, 2009
Prechemotherapy alterations in brain function in women with breast cancerBernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, et al.
Journal of the National Cancer Institute|August 21, 2013
Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNAJames M Rae, Meredith M Regan, Jacklyn N Thibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663Mary-Ellen Taplin, Barur Rajeshkumar, Susan Halabi, et al.
Pageof 34

Showing results (151-160 of 336) with videos related to

Sort By:
Pageof 34
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Journal of Medicinal Chemistry|April 17, 2019
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)Jiantao Hu, Biao Hu, Mingliang Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selectionShelly S Lo, Patricia B Mumby, John Norton, et al.
Annals of Surgical Oncology|May 22, 2007
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentationErika A Newman, Michael S Sabel, Alexis V Nees, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 7, 2013
Pretreatment worry and neurocognitive responses in women with breast cancerMarc G Berman, Mary K Askren, Misook Jung, et al.
Journal of Virology|July 18, 2008
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancerRafael Contreras-Galindo, Mark H Kaplan, Philippe Leissner, et al.
Journal of Clinical and Experimental Neuropsychology|July 31, 2009
Prechemotherapy alterations in brain function in women with breast cancerBernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, et al.
Journal of the National Cancer Institute|August 21, 2013
Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNAJames M Rae, Meredith M Regan, Jacklyn N Thibert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663Mary-Ellen Taplin, Barur Rajeshkumar, Susan Halabi, et al.
Pageof 34